India to Colombia: Salbutamol Export Trade Route

The India to Colombia Salbutamol corridor is one of India's established pharmaceutical export routes, with 159 shipments documented worth a combined $5.1M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 64% of all export value, reflecting the consolidated nature of India's salbutamol manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $32.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with salbutamol's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 34.2%, placing it at rank #13 among India's top salbutamol export destinations globally.

On the import side, key buyers of Indian salbutamol in Colombia include CIPLA COLOMBIA SAS Y O DEPOSITO UP, CIPLA COLOMBIA SAS Y/O DEPOSITO UPS, CIPLA COLOMBIA SAS Y/O DEPOSITO UPS and 12 others. CIPLA COLOMBIA SAS Y O DEPOSITO UP is the single largest importer with 33 shipments valued at $1.1M USD.

India's salbutamol exports to Colombia are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 98 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Colombia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED , MEDISPRAY LABORATORIES PRIVATE LIMITED — together account for 93% of total trade value on this route. The average shipment value of $32.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as salbumed 100 mcg hfa inhaler salbutamol sulphate 100 mcg 1 x200 md and salbumed 100 mcg hfa inhaler (salbutamol sulphate 100 mcg) (1 x200 md)., suggesting that buyers in Colombia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, CIPLA COLOMBIA SAS Y O DEPOSITO UP is the largest importer with 33 shipments worth $1.1M USD — representing 21% of all salbutamol imports from India on this route. A total of 15 buyers are active on this corridor.